Labcorp Holdings Inc.
LH · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 11.86B | 3.71B | 1.44B | 1.28B | 14.04 |
| 2023 FY | 12.16B | 3.36B | 725.60M | 418.00M | 4.80 |
| 2024 FY | 13.01B | 3.62B | 1.09B | 746.00M | 8.89 |
| 2025 FY | 13.95B | 3.73B | 1.52B | 876.50M | 10.54 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 20.16B | 10.04B | 320.60M | 6.25B | 10.10B |
| 2023 FY | 16.73B | 8.83B | 536.80M | 5.95B | 7.88B |
| 2024 FY | 18.38B | 10.31B | 1.52B | 7.27B | 8.05B |
| 2025 FY | 18.39B | 9.76B | 532.30M | 7.20B | 8.62B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 1.96B | -481.90M | 1.47B | -195.20M | -1.04B |
| 2023 FY | 1.33B | -453.60M | 874.10M | -254.00M | 106.80M |
| 2024 FY | 1.59B | -489.90M | 1.10B | -243.10M | 981.90M |
| 2025 FY | 1.64B | -434.50M | 1.21B | -240.70M | -986.40M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 18.43B | 24.35B | — | — | — |
| 2023 FY | 19.80B | 25.21B | — | — | — |
| 2024 FY | 19.24B | 24.99B | — | — | — |
| 2025 FY | 20.87B | 27.54B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 3.53B | 1.05B | 394.50M | 237.90M | 2.86 |
| 2025 Q3 | 3.56B | 1.03B | 396.60M | 261.10M | 3.14 |
| 2025 Q4 | 3.52B | 920.60M | 382.00M | 164.70M | 2.00 |
| 2026 Q1 | 3.54B | 938.20M | 387.20M | 277.80M | 3.37 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 18.06B | 9.57B | 647.30M | 6.55B | 8.47B |
| 2025 Q3 | 18.26B | 9.55B | 598.10M | 7.22B | 8.70B |
| 2025 Q4 | 18.39B | 9.76B | 532.30M | 7.21B | 8.62B |
| 2026 Q1 | 19.09B | 10.34B | 981.10M | 7.24B | 8.73B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 620.60M | -77.90M | 542.70M | -59.90M | 277.90M |
| 2025 Q3 | 387.20M | -106.70M | 280.50M | -59.90M | -49.20M |
| 2025 Q4 | 614.20M | -123.90M | 490.30M | -59.30M | -65.80M |
| 2026 Q1 | 191.50M | -121.00M | 70.50M | -61.20M | 448.80M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 21.92B | 27.82B | — | — | — |
| 2025 Q3 | 23.85B | 30.48B | — | — | — |
| 2025 Q4 | 20.70B | 27.37B | — | — | — |
| 2026 Q1 | 21.96B | 28.22B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |